CASE REPORT 78 79
A 18-year-old woman with no previous medical history was referred in October 2013 for 80 fatigue and weight loss, without any bone pain nor arthalgia. She was diagnosed with 81 common acute lymphoblastic leukemia (ALL) without central nervous system involvement. 82
The initial white blood cells count was 2 X 10 9 /L. The karyotype showed an isochromosome 83 i(9)(q10) as sole abnormality. Initial gammaglobuline was 6,5 g/L. After a steroid prophase, 84
she underwent a BFM-like induction course according to pediatric FRALLE-2000B trial 85 including vincristine, oral prednisolone, daunorubicin, L-asparaginase and triple intrathecal 86 chemotherapy (methotrexate, cytosine arabinoside and depomedrol). 87
On day 29, while the patient was recovering from neutropenia without granulocyte colony 88 stimulating factor, joint pains (ankles and knees) with odynophagia and mild fever occurred. 89
At that time, the patient was still receiving prednisolone 40 mg/sqm/d and prophylactic 90 piperacillin/tazobactam. 91
The pain worsened after corticosteroid withdrawal. On day 36, she was admitted with painfull 92 tender swelling and redness over the index proximal and distal interphalangeal joint, the right 93 elbow, the right hip, and the left temporomandibular joint with limited mouth opening. 94
Moreover, she had developed axial involvement with lumbar spine pain with stiffness. 95
Temperature was 38°C. C-reactive protein was 101 mg/L, ferritine 2652 μg/L, fibrinogen 96 7,31g/L; WBC count was 8 X 10 9 /L, with lymphocyte 0.88 X 10 9 /L, hemoglobin 97 g/L and 97 gammaglobuline 3.1 g/L. Joint radiography and whole spine MRI were normal. 98
Hip fluid aspiration performed on day 45 revealed 51900 leukocytes/mm 3 (70% 99 polymorphonuclear cells), no crystals, no bacteria in culture and no leukemic blasts. Urine 100 testing for Chlamydia trachomatis and Neisseria gonorrheae were negative. Broad viral 101 genome detection including CMV, EBV, Parvovirus B19, Enterovirus, Adenovirus, HHV-6, 102 HSV, VZV from blood and joint fluid was negative. Antistreptolysin, circulating anti-cyclic 103 citrullinated peptide, rheumatoid factor and antinuclear antibodies were not detected. HLA 104 B27 and B51 were absent. Lyme and brucellosis serologies were negative. Glycosylated 105 ferritin was normal. 106
The patient has no personal history of psoriasis. Her mother was previously diagnosed with 107 elbow and knee rashes evocative of psoriasis. Due to this first-degree relative history, the 108 presence of dactylitis, axial involvement, and absence of rheumatoid factor, the diagnosis of 109 psoriatic arthritis was first made. Prednisolone 20mg and ketoprofen 100mg twice daily were 110 reintroduced on day 37 and 45 respectively. On day 61, due to pain exacerbation, tocilizumab 111 400mg was administered with poor clinical efficacy. 112
In this context of therapy escalation, we decided to test the hip fluid onto the PLEX-ID 113 platform, which combines a broad-range PCR for bacterial DNA detection with electrospray 114 ionization mass spectrometry. Nucleic acids were extracted, from 1mL of the hip fluid, by a 115 magnetic beads based method with the nSP instrument, using the DNA Preparation kit (all 116 from Abbott Ibis Biosciences). PLEX-ID analysis was performed with the PLEX-ID BAC 117
Assay, devoted to bacterial broad Spectrum Amplification (AbbottIbis Biosciences, Carlsbad, 118 CA, USA). After mass spectrometry of the amplicons, the PLEX-ID software converted the 119 mass information into base compositions and determined the bacteria DNA present in the 120 samples by comparing the base composition signature to a database. The system usually takes 121 6 hours from DNA extraction to provide final semi-quantitative results. In the present case, at 122 day 71, the signal detected in the hip fluid sample suggested a strong positivity for U. 123 urealyticum. On the PLEX-ID system, Ureaplasma are expected to be detected by 3 primer 124
pairs. As previously reported, Ureaplasma parvum and Ureaplasma urealyticum may be 125 differentiated by 2 of the 3 primer pairs (5). 126
In order to confirm presence of the bacteria and to test antiobitic susceptibility, a knee joint 127 puncture was performed and grown on specific Shepard media containing urea. The U. urealyticum is causally linked to disseminated infections in newborns but also in 146 immunocompromised patients suffering from hypogammaglobulinaemia (common variable 147 immunodeficiency or other B-cell deficiencies) (6, 7), or after renal transplant (3), or 148 lymphoma (1) or even after rituximab therapy for systemic lupus erythematosus without 149
hypogammaglobulinaemia (8). 150
We report here the first patient who developed a rapidly progressive bilateral and symmetric 151 septic polyarthritis with axial involvement due to U. urealyticum following induction course 152 for acute lymphoblastic leukemia (ALL). The diagnosis was first oriented by a new assay 153 based on broad-range PCR followed by Electrospray Ionization Mass Spectrometry 154 (PCR/ESI-MS, PLEX ID system, Abbott Ibis Biosciences, Carlsbad, CA) (4, 10) and 155 confirmed by positive culture isolation (15) . 156
157
The present case is remarkable for several reasons. First, in the literature, delay observed in 158 identifying the causative agent U. urealyticum ranging from 4 weeks to 4 months (2), as 159 ureaplasma are often not considered early in the clinical course. Here, time to diagnosis was 160 four weeks, shortened by the use of the ESI TOF mass spectrometry, an innovating molecular 161 biology technique overpassing the wide bacterial diversity. Indeed, the promising PLEX-ID 162 system provides a rapid method for the detection of a broad array of bacteria directly in 163 several specimens (articular fluid, blood, respiratory samples,...) and has the potential of 164 impacting patient outcome by reducing the need to wait for the culture. Second, septic 165 arthritis with U. urealyticum is an infection typically seen in patients with common variable 166 immunodeficiency (CVID) and hypogammaglobulinemia (2, 13), but to date, never described 167 during ALL therapy. Patient medical history was not suggestive of CVID. Third, this case 168 should raise clinician awareness of such infections with negative standard cultures in 169 immunocompromised patients, since specific bacteriological techniques (specialized culture 170 for detection) are required for early diagnosis and therapy. Fourth, the promptly response to 171 antibiotics allowed ad integrum recovery without any joint destruction. Fifth, ureaplasma 172 resistance to tetracyclines is very low, approximately 5% (9). The culture isolation enabled to 173 determine the antibiotic sensitivity profile, very useful in this case, and cannot be replaced by 174 molecular techniques to date, although PCR-ESI-MS detections allow for the initial 175 antimicrobial therapy to be based on the organism present, resulting in more optimal care and 176 outcome for this patient. In conclusion, the PLEX-ID system provides a rapid method for the 177
